| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 07/11/1996 | CA2208664A1 Functionalised photoinitiators, derivatives and macromers therefrom and their use |
| 07/10/1996 | EP0720995A2 Liquid reactive thermosetting compositions and process for their crosslinking |
| 07/10/1996 | EP0720852A1 Remedy for nervous diseases |
| 07/10/1996 | EP0720605A1 Aminocyclohexylesters and uses thereof |
| 07/10/1996 | EP0720597A1 Triaryl-ethylene derivatives for use in therapy |
| 07/10/1996 | CN1126474A Polymerizable compounds |
| 07/10/1996 | CN1126466A Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 07/09/1996 | US5534629 α-aminoacetophenones as photoinitiators |
| 07/09/1996 | US5534533 Carboxylate derivatives exhibiting phospholipase A2 inhibitory activity |
| 07/08/1996 | EP0738138A4 Quaternary salts of para-dialkylamino benzamide derivatives |
| 07/04/1996 | WO1996020172A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED β-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
| 07/04/1996 | WO1996019995A1 4,4-(disubstituted)cyclohexan-1-one monomers and related compounds |
| 07/04/1996 | CA2208456A1 4,4-(disubstituted)cyclohexan-1-one monomers and related compounds |
| 07/03/1996 | EP0719558A1 Ranolazine and related piperazines for use in the treatment of shock conditions |
| 07/03/1996 | EP0719267A1 Second messenger cell signaling inhibitors |
| 07/03/1996 | EP0719244A1 Process of preparing 2,3,5-trihalobenzaldehyde |
| 07/03/1996 | CN1125938A Bicyclic amide derivatives and their use as muscle relaxants |
| 07/02/1996 | US5532383 Leukotriene B4 antagonists |
| 07/02/1996 | US5532371 Piperazine substituted carboxylic acid derivatives for treating hyperlipimia |
| 07/02/1996 | US5532266 Treatment of hypoxia, antiedemic agents or antiinflammatory agents |
| 07/02/1996 | US5532259 Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use |
| 07/02/1996 | US5532255 Anticoagulants, cardiovascular disorders, antiinflammatory agents, arteriosclerosis or antitumor agents |
| 07/02/1996 | US5532242 Central nervous system cognition activators, anxiety and antidepressants |
| 07/02/1996 | US5531978 Aminopolycarboxylic acids and derivatives thereof |
| 06/27/1996 | WO1996019455A1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 06/27/1996 | WO1996019449A1 Fluorobutenyl(thio)ethers used as pesticides |
| 06/27/1996 | WO1996019437A1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
| 06/27/1996 | DE4445792A1 Fluorbutenyl(thio)ether Fluorbutenyl (thio) ether |
| 06/27/1996 | CA2208011A1 Aryl-and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 06/26/1996 | EP0718287A2 Piperazine derivatives, medicaments containing them, their use, and processes for their preparation |
| 06/26/1996 | EP0718280A2 Derivatives of beta-aminopropionic acid with a fungicidal activity |
| 06/26/1996 | EP0717736A1 Polar-substituted hydrocarbons |
| 06/26/1996 | EP0717731A1 Difluoro statone antiviral analogs |
| 06/26/1996 | EP0575361B1 New 1-aryl-4-piperazinyl-cyclohexanecarboxylic acid nitriles, their production and their use |
| 06/26/1996 | CN1125436A Vitamin D amide derivatives |
| 06/26/1996 | CN1125397A Digestive symptom ameliorant |
| 06/25/1996 | US5530128 Enzyme inhibitor as antitumor agent |
| 06/25/1996 | US5530118 Phospholipase inhibitor |
| 06/25/1996 | US5530002 Anidepressant, anxiolytic agent, hypotensive and treats disorders linked to alcoholism, sleep, phobias, obsessive compulsive behavior and migraine |
| 06/24/1996 | CA2165922A1 Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation |
| 06/22/1996 | CA2164904A1 Liquid reactive thermosetting compositions and process for their cross-linking |
| 06/20/1996 | WO1996018391A2 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 06/20/1996 | WO1996004241A3 Benzoylguanidine derivatives as medicaments |
| 06/19/1996 | EP0716656A1 Amide derivatives as 5ht1d receptor antagonists |
| 06/19/1996 | EP0716603A1 Methods and compositions for inhibiting uridine secretion |
| 06/19/1996 | EP0535250B1 Novel compounds and use thereof as medicine |
| 06/18/1996 | US5527829 HIV protease inhibitors |
| 06/18/1996 | US5527821 For treatment of urinary incontinence |
| 06/18/1996 | US5527777 Peptide compounds, in particular LHRH-antagonists |
| 06/12/1996 | EP0716084A1 Preparation of 4,4'-(oxydi-2,1-ethanediyl)bis-morpholine and hydroxyethoxyethyl morpholine |
| 06/12/1996 | EP0716077A1 Aromatically substituted omega amino alcanoic acid amides and alcanoic diamides and their use as renine inhibitors |
| 06/12/1996 | EP0716076A2 Bisphenolester derivatives |
| 06/12/1996 | EP0594715B1 Preparation of diaminic compounds and intermediates |
| 06/12/1996 | EP0556322B1 Aminosulfonyl urea acat inhibitors |
| 06/12/1996 | EP0515420B1 Nitric acid esters of cyclohexanol derivatives |
| 06/12/1996 | CN1124485A Novel 1-phenylalkanone 5-HT4 receptor ligands |
| 06/12/1996 | CN1124140A Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administration |
| 06/12/1996 | CN1031992C Quinone derivatives and pharmaceutical use |
| 06/11/1996 | US5525633 Triaryl-ethylene derivatives |
| 06/11/1996 | CA2030397C 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1- piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
| 06/10/1996 | CA2155722A1 Preparation of 4,4'-(oxydi-2,1-ethanediyl)bis-morpholine and hydroxyethoxyethyl morpholine |
| 06/09/1996 | CA2164571A1 Aromatically substituted w-amino-alkanoic acid amides and alkanoic acid diamides |
| 06/06/1996 | WO1996016980A1 Morpholinoethylamide derivatives |
| 06/06/1996 | WO1996016930A1 Succinic acid derivatives and their use as surfactants |
| 06/06/1996 | WO1996016646A1 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
| 06/06/1996 | CA2206422A1 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
| 06/06/1996 | CA2205867A1 Succinic acid derivatives and their use as surfactants |
| 06/06/1996 | CA2164278A1 Bisphenol ester derivatives |
| 06/05/1996 | EP0714660A1 Ranolazine and related piperazines for protecting skeletal muscles |
| 06/05/1996 | EP0714389A1 Amide and urea derivatives as 5ht1d receptor antagonists |
| 06/05/1996 | EP0714292A1 Sigma receptor ligands and the use thereof |
| 06/04/1996 | US5523464 Bone disorders |
| 06/04/1996 | US5523462 Cyclohexenone derivatives |
| 06/04/1996 | US5523325 Amidrazones and their use as pesticides |
| 06/04/1996 | US5523304 Reversal of multi-drug resistance by tetraarylethylenes |
| 06/04/1996 | US5523303 Antiulcer and -secretory agents; gastric h+k+ atpase inhibitors; nontoxic; oximes derivatives |
| 06/04/1996 | US5523302 Anticoagulants, cardiovascular disorders |
| 06/04/1996 | US5523289 Renin inhibitor |
| 05/30/1996 | WO1996016058A1 Aminomethyl aryl compounds; dopamine receptor subtype selective ligands |
| 05/30/1996 | WO1996016052A2 Certain substituted 1-aryl-3-piperazin-1'-yl propanones |
| 05/30/1996 | WO1996016027A1 Matrix metalloprotease inhibitors |
| 05/30/1996 | WO1996016026A1 O-benzyl oxime ether derivatives and their use as pesticides |
| 05/30/1996 | WO1996015792A1 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1'-yl propanones |
| 05/30/1996 | WO1996015791A2 Use of substituted aryl-morpholino-, thiomorpholino- or piperazino-propanones for the treatement of prevention of alzheimer'disease |
| 05/30/1996 | WO1996015781A1 Use of nitric oxide-releasing agents for reducing metastasis risk |
| 05/30/1996 | CA2205969A1 Aminomethyl aryl compounds; dopamine receptor subtype selective ligands |
| 05/30/1996 | CA2205665A1 Matrix metalloprotease inhibitors |
| 05/30/1996 | CA2205586A1 Certain substituted 1-aryl-3-piperazin-1'-yl propanones |
| 05/30/1996 | CA2205504A1 Certain substituted 1-aryl-3-piperazin-1'-yl propanones |
| 05/30/1996 | CA2203507A1 O-benzyl oxime ether derivatives and their use as pesticides |
| 05/29/1996 | EP0713483A1 Amidine derivatives with nitric oxide synthetase activities |
| 05/29/1996 | CN1031880C Process for preparing novel analogs of peptidase substrates |
| 05/28/1996 | US5521311 Useful as antiinflammatory agents, antipyretics, analgesics and anti-allergenic agents |
| 05/28/1996 | US5521220 Treating inflammatory and central nervous system disorders |
| 05/28/1996 | US5521214 2-phenyl-3-aroylbenzothiophenes |
| 05/28/1996 | US5521212 Cyclopropyl N-hydroxyurea and N-hydroxyacetamides which inhibit lipoxygenase |
| 05/28/1996 | US5521199 Piperidinyl compounds as neurokinin receptor antagonists |
| 05/28/1996 | US5520707 Cationic hair dyes |
| 05/23/1996 | WO1996015148A2 Low molecular weight peptidomimetic growth hormone secretagogues |
| 05/23/1996 | WO1996015096A1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |